Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10017 | 1098 | 36.5 | 58% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
449 | 3 | FAMILIAL MEDITERRANEAN FEVER//TOLL LIKE RECEPTORS//INFLAMMASOME | 25887 |
1872 | 2 | LIPID A//ENDOTOXIN//LIPID A ANALOG | 6024 |
10017 | 1 | ANTILIPID A//ANTIBIOTIC INDUCED ENDOTOXIN RELEASE//ANTILIPOPOLYSACCHARIDE | 1098 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANTILIPID A | authKW | 115867 | 0% | 83% | 5 |
2 | ANTIBIOTIC INDUCED ENDOTOXIN RELEASE | authKW | 83425 | 0% | 100% | 3 |
3 | ANTILIPOPOLYSACCHARIDE | authKW | 83425 | 0% | 100% | 3 |
4 | JOURNAL OF ENDOTOXIN RESEARCH | journal | 58278 | 3% | 6% | 34 |
5 | ANTIENDOTOXIN MONOCLONAL ANTIBODIES | authKW | 55617 | 0% | 100% | 2 |
6 | ENDOTOXIN ANTIBODY | authKW | 55617 | 0% | 100% | 2 |
7 | ANTI LIPOPOLYSACCHARIDE ANTIBODIES | authKW | 50053 | 0% | 60% | 3 |
8 | HA 1A | authKW | 50053 | 0% | 60% | 3 |
9 | ENDOTOXIN NEUTRALIZING CAPACITY | authKW | 41710 | 0% | 50% | 3 |
10 | ENDOTOXIN | authKW | 39261 | 8% | 2% | 88 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Infectious Diseases | 8822 | 27% | 0% | 296 |
2 | Microbiology | 6323 | 32% | 0% | 353 |
3 | Immunology | 5057 | 33% | 0% | 364 |
4 | Critical Care Medicine | 936 | 6% | 0% | 66 |
5 | Medicine, General & Internal | 323 | 9% | 0% | 104 |
6 | Surgery | 205 | 9% | 0% | 104 |
7 | Pharmacology & Pharmacy | 185 | 10% | 0% | 111 |
8 | Medicine, Research & Experimental | 70 | 4% | 0% | 46 |
9 | BIOLOGY, MISCELLANEOUS | 68 | 0% | 0% | 2 |
10 | Hematology | 46 | 3% | 0% | 31 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EDINBURGH SE SCOTLAND REG TRANSFUS | 37077 | 0% | 67% | 2 |
2 | ANTIMICROBIAL PROGRAM | 27808 | 0% | 100% | 1 |
3 | CITY SCI BIOTECHNOL PLICAT | 27808 | 0% | 100% | 1 |
4 | CNRS UA 579 | 27808 | 0% | 100% | 1 |
5 | EUROPEAN ANIM HLTH CLIN DEV | 27808 | 0% | 100% | 1 |
6 | GEN MEDD | 27808 | 0% | 100% | 1 |
7 | HIROSHIMA MUNICIPAL FUNAIRI HOSP | 27808 | 0% | 100% | 1 |
8 | IMMUNOL MICROBIOL BRANCH | 27808 | 0% | 100% | 1 |
9 | INFECT DISMSTF | 27808 | 0% | 100% | 1 |
10 | KING KALID UNIV HOSP | 27808 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF ENDOTOXIN RESEARCH | 58278 | 3% | 6% | 34 |
2 | SERODIAGNOSIS AND IMMUNOTHERAPY IN INFECTIOUS DISEASE | 23750 | 1% | 9% | 10 |
3 | JOURNAL OF INFECTIOUS DISEASES | 13595 | 8% | 1% | 93 |
4 | CIRCULATORY SHOCK | 6012 | 1% | 1% | 16 |
5 | INFECTION | 4595 | 2% | 1% | 25 |
6 | INFECTION AND IMMUNITY | 4487 | 6% | 0% | 66 |
7 | ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION B-MICROBIOLOGY | 3523 | 0% | 3% | 4 |
8 | ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII | 2256 | 1% | 1% | 16 |
9 | EOS-RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA | 1832 | 1% | 1% | 6 |
10 | REVIEWS OF INFECTIOUS DISEASES | 1830 | 1% | 1% | 13 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HOLZHEIMER, RG , (2001) ANTIBIOTIC INDUCED ENDOTOXIN RELEASE AND CLINICAL SEPSIS: A REVIEW.JOURNAL OF CHEMOTHERAPY. VOL. 13. ISSUE . P. 159-172 | 68 | 64% | 54 |
2 | GREISMAN, SE , JOHNSTON, CA , (1997) EVIDENCE AGAINST THE HYPOTHESIS THAT ANTIBODIES TO THE INNER CORE OF LIPOPOLYSACCHARIDES IN ANTISERA RAISED BY IMMUNIZATION WITH ENTEROBACTERIAL DEEP-ROUGH MUTANTS CONFER BROAD-SPECTRUM PROTECTION DURING GRAM-NEGATIVE BACTERIAL SEPSIS.JOURNAL OF ENDOTOXIN RESEARCH. VOL. 4. ISSUE 2. P. 123-153 | 80 | 63% | 13 |
3 | HURLEY, JC , NOWAK, P , OHRMALM, L , GOGOS, C , ARMAGANIDIS, A , GIAMARELLOS-BOURBOULIS, EJ , (2015) ENDOTOXEMIA AS A DIAGNOSTIC TOOL FOR PATIENTS WITH SUSPECTED BACTEREMIA CAUSED BY GRAM-NEGATIVE ORGANISMS: A META-ANALYSIS OF 4 DECADES OF STUDIES.JOURNAL OF CLINICAL MICROBIOLOGY. VOL. 53. ISSUE 4. P. 1183 -1191 | 32 | 68% | 3 |
4 | HURLEY, JC , (2010) DOES GRAM-NEGATIVE BACTERAEMIA OCCUR WITHOUT ENDOTOXAEMIA? A META-ANALYSIS USING HIERARCHICAL SUMMARY ROC CURVES.EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. VOL. 29. ISSUE 2. P. 207 -215 | 36 | 67% | 6 |
5 | HURLEY, JC , OPAL, SM , (2013) PROGNOSTIC VALUE OF ENDOTOXEMIA IN PATIENTS WITH GRAM-NEGATIVE BACTEREMIA IS BACTERIAL SPECIES DEPENDENT.JOURNAL OF INNATE IMMUNITY. VOL. 5. ISSUE 6. P. 555 -564 | 33 | 59% | 6 |
6 | MITOV, IG , TERZIISKI, DG , (1991) IMMUNOPROPHYLAXIS AND IMMUNOTHERAPY OF GRAM-NEGATIVE SEPSIS AND SHOCK WITH ANTIBODIES TO CORE GLYCOLIPIDS AND LIPID-A OF BACTERIAL LIPOPOLYSACCHARIDES.INFECTION. VOL. 19. ISSUE 6. P. 383-390 | 48 | 84% | 9 |
7 | HURLEY, JC , (2009) DIAGNOSIS OF ENDOTOXEMIA WITH GRAM-NEGATIVE BACTEREMIA IS BACTERIAL SPECIES DEPENDENT: A META-ANALYSIS OF CLINICAL STUDIES.JOURNAL OF CLINICAL MICROBIOLOGY. VOL. 47. ISSUE 12. P. 3826-3831 | 29 | 71% | 5 |
8 | DUNN, DL , (1993) CONTROVERSIES REGARDING THE USE OF ANTIENDOTOXIN MONOCLONAL-ANTIBODIES.INFECTIOUS DISEASES IN CLINICAL PRACTICE. VOL. 2. ISSUE 6. P. 456-462 | 41 | 82% | 0 |
9 | HUSTINX, WNM , KRAAIJEVELD, K , HOEPELMAN, AIM , VERHOEF, J , (1997) CROSS-PROTECTION BY ANTI-CORE GLYCOLIPID ANTIBODIES: EVIDENCE FROM ANIMAL EXPERIMENTS.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 40. ISSUE 4. P. 475-483 | 42 | 67% | 5 |
10 | HEALY, DP , VERSTBRASCH, CL , CLENDENING, CE , NEELY, AN , HOLDER, IA , (1996) INFLUENCE OF DRUG CLASS AND DOSE SIZE ON ANTIBIOTIC-INDUCED ENDOTOXIN/IL-6 RELEASE AND IMPACT ON EFFICACY OF ANTI-ENDOTOXIN ANTIBODY.JOURNAL OF ENDOTOXIN RESEARCH. VOL. 3. ISSUE 3. P. 219-227 | 30 | 94% | 4 |
Classes with closest relation at Level 1 |